Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rosti

Showing results (91-100 of 198) with videos related to

Pageof 20
Sort By:
Tumori|March 1, 1996
[High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors]G Rosti, P Ferrante, A Tienghi, et al.
Leukemia Research|January 1, 1991
Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemiaA Zaccaria, G Rosti, N Testoni, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Primary gastric lymphoma: a review of 45 casesA Ravaioli, M Amadori, M Faedi, et al.
Bone Marrow Transplantation|August 1, 1993
In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMTG Martinelli, E Trabetti, A Zaccaria, et al.
Leukemia|June 1, 1992
Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplantsA Guerrasio, G Martinelli, G Saglio, et al.
Bone Marrow Transplantation|January 1, 1993
New strategies for selection of unrelated bone marrow donorsG Martinelli, M Buzzi, P Farabegoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Epirubicin + G-CSF as peripheral blood progenitor cells (PBPC) mobilising agents in breast cancer patientsG Rosti, L Albertazzi, P Ferrante, et al.
The International Journal of Biological Markers|October 1, 1990
Radioimmunotherapy trials in germ testicular carcinoma: a phase I studyP Riva, M Marangolo, V Tison, et al.
Bone Marrow Transplantation|July 15, 2003
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancerU De Giorgi, G Rosti, A Zaniboni, et al.
Pageof 20

Showing results (91-100 of 198) with videos related to

Sort By:
Pageof 20
Tumori|March 1, 1996
[High-dose chemotherapy and peripheral hemtopoietic cells (PBPC) in solid tumors]G Rosti, P Ferrante, A Tienghi, et al.
Leukemia Research|January 1, 1991
Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemiaA Zaccaria, G Rosti, N Testoni, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Primary gastric lymphoma: a review of 45 casesA Ravaioli, M Amadori, M Faedi, et al.
Bone Marrow Transplantation|August 1, 1993
In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMTG Martinelli, E Trabetti, A Zaccaria, et al.
Leukemia|June 1, 1992
Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplantsA Guerrasio, G Martinelli, G Saglio, et al.
Bone Marrow Transplantation|January 1, 1993
New strategies for selection of unrelated bone marrow donorsG Martinelli, M Buzzi, P Farabegoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow TransplantationS Leyvraz, L Perey, G Rosti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Epirubicin + G-CSF as peripheral blood progenitor cells (PBPC) mobilising agents in breast cancer patientsG Rosti, L Albertazzi, P Ferrante, et al.
The International Journal of Biological Markers|October 1, 1990
Radioimmunotherapy trials in germ testicular carcinoma: a phase I studyP Riva, M Marangolo, V Tison, et al.
Bone Marrow Transplantation|July 15, 2003
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast cancerU De Giorgi, G Rosti, A Zaniboni, et al.
Pageof 20